|
|
|
|
pmid:
|
Werbovetz KA et al. |
Purification, characterization, and drug susceptibility of tubulin from Leishmania. |
1999 |
Mol. Biochem. Parasitol. |
pmid:10029309
|
Suchocki JA and Sneden AT |
Characterization of decomposition products of maytansine. |
1987 |
J Pharm Sci |
pmid:11002812
|
Havens CG et al. |
Cellular effects of leishmanial tubulin inhibitors on L. donovani. |
2000 |
Mol. Biochem. Parasitol. |
pmid:11071278
|
Monneret C and Florent JC |
[Targeting of antitumor drugs with monoclonal antibodies]. |
2000 |
Bull Cancer |
pmid:11125291
|
Smith S |
Technology evaluation: C242-DM1, ImmunoGen Inc. |
2001 |
Curr. Opin. Mol. Ther. |
pmid:11338934
|
Carroll BJ et al. |
Identification of a set of genes involved in the formation of the substrate for the incorporation of the unusual "glycolate" chain extension unit in ansamitocin biosynthesis. |
2002 |
J. Am. Chem. Soc. |
pmid:11960423
|
Ross S et al. |
Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. |
2002 |
Cancer Res. |
pmid:11980648
|
Moss SJ et al. |
Identification of asm19 as an acyltransferase attaching the biologically essential ester side chain of ansamitocins using N-desmethyl-4,5-desepoxymaytansinol, not maytansinol, as its substrate. |
2002 |
J. Am. Chem. Soc. |
pmid:12047169
|
Yu TW et al. |
The biosynthetic gene cluster of the maytansinoid antitumor agent ansamitocin from Actinosynnema pretiosum. |
2002 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12060743
|